The board is tasked with assisting the ophthalmology pharmaceutical company in advancing treatment products for patients with ophthalmic diseases, according to an Aug. 2 press release. Carl Regillo, M.D., chief of retina service at Wills Eye Hospital, will chair the board.
Other board members are:
- Sophie Bakri, M.D., Mayo Clinic
- Caroline Baumal, M.D., Tufts Medical Center
- David Boyer, M.D., University of Southern California Keck School of Medicine
- Glenn Jaffe, M.D., Duke University
- Rishi Singh, M.D., Cleveland Clinic
- Charles Wykoff, M.D., Ph.D., Retina Consultants of Texas
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
